Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06587984 · ClinicalTrials.gov registry record · NA

Influenza Reminder Text-Messaging

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
228,361
Enrollment target

NCT06587984: Completed NA study, sponsored by Children's Hospital of Philadelphia.

NCT06587984 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 228,361 participants, above the 1,400-participant average among 58,714 other NA trials with a reported enrollment target (16212% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06587984, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
228,361 participants
Enrollment target

Study Summary

Through a large, population-level quality improvement effort within the Children's Hospital of Philadelphia Care Network, we will evaluate text message reminders on flu vaccination rates for both patients with and without a scheduled well child care visit during flu season.

Primary Outcome

Via prospective chart review, the primary outcome for both Cohort 1 and Cohort 2 will be to assess the number of patients who received an influenza vaccination 30 days post-text message reminder (baseline). Data from chart review will determine vaccination status (patient received influenza vaccination or not).

Interventions

  • BEHAVIORAL Text message reminder

Trial Details

FieldValue
Enrollment Target 228,361 participants
Start Date 2024-09-03
Est. Completion 2024-12-31
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT06587984 record still lists

NCT06587984 is an interventional study that assigns participants to a tested intervention. Its 228,361 participants enrollment target places it among the larger protocols in the corpus, above the 1,400-participant average among 58,714 other NA trials with a reported enrollment target (16212% higher).

The record links to 0 conditions, and to 1 intervention - of which Text message reminder is the first listed.

NCT06587984 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06587984 about?

NCT06587984 is a clinical study titled "Influenza Reminder Text-Messaging". Through a large, population-level quality improvement effort within the Children's Hospital of Philadelphia Care Network, we will evaluate text message reminders on flu vaccination rates for both patients with and without a scheduled well child care visit during flu season.

What is the current status of trial NCT06587984?

This trial is currently completed. It is a NA study. The enrollment target is 228,361 participants. The study started on 2024-09-03. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT06587984?

The interventions under investigation include: Text message reminder (BEHAVIORAL).

Who is sponsoring clinical trial NCT06587984?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06587984's enrollment target sits among peer trials

228,361 1st of 2000 higher than 2,000 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04735835 · 250,000 participants · NA

    Personalized Responses to Dietary Composition Trial 3

  • NCT06090578 · 180,000 participants · NA

    TabCAT Brain Health Assessment in Primary Care

  • NCT02280733 · 300,000 participants

    A Real-World Registry of Chronic Wounds and Ulcers

  • NCT06694181 · 300,000 participants

    Safe and Explainable AI

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06587984, the US trial registry maintained by the National Library of Medicine. NCT06587984 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.